Dissolved and financials
CVR: 37667269
Previous names: NuBiotrient IVS
DKK 69,614
Revenue
Net result: DKK 29,125
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 14 December 2020
CVR · view overview
No headcount reported
Director role ended: Claus Vesterskov Lyng
CVR · 14/12/2020
View the full event history
Sunlit IVS was a Danish company of the type Iværksætterselskab based in Skævinge, founded in 2016. The company has been dissolved on 14 December 2020. The company was registered under the industry Industriel design og produktdesign. The company was previously named NuBiotrient IVS. In 2019, the company reported revenue of DKK 69,614 and a net result of DKK 29,125 compared with DKK -78,874 the year before. Equity in the 2019 report amounted to DKK 118,527.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 201901/01/2019 – 31/12/2019 | 70 t. | 29 t. | 200 t. | 119 t. | - | |
| 201801/01/2018 – 31/12/2018 | 800 | -79 t. | 118 t. | 39 t. | - | |
| 201701/01/2017 – 31/12/2017 | 5 t. | -83 t. | 158 t. | 43 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningNo. Sunlit IVS is registered in the Danish CVR register with the status Dissolved and ceased on 14 December 2020.
The CVR number of Sunlit IVS is 37667269.
In 2019, Sunlit IVS reported revenue of DKK 69,614.
Sunlit IVS was founded on 5 May 2016.
Sunlit IVS was registered under the industry Industriel design og produktdesign (industry code 741010).
Sunlit IVS was located at Meløsevej 9, 3320 Skævinge.
As of December 14, 2020, Claus Vesterskov Lyng has stepped down as director of Sunlit IVS.
Sunlit IVS was dissolved on December 14, 2020.
Sunlit IVS has published its annual report for 2019. Revenue came to DKK 69,614, and the net result was DKK 29,125.
On September 19, 2019, the company changed its name from NuBiotrient IVS to Sunlit IVS.
Sunlit IVS has published its annual report for 2018. Revenue came to DKK 800, and the net result was DKK -78,874.
Sunlit IVS has published its annual report for 2017. Revenue came to DKK 4,800, and the net result was DKK -83,293.
Sunlit IVS has published its interim report for the period May 5, 2016 to December 31, 2016.
As of May 5, 2016, Claus Vesterskov Lyng is registered as director of Sunlit IVS.
Sunlit IVS was founded on May 5, 2016.
